Status:
RECRUITING
Myocardial and Arterial Phenotype of Coronary Artery Disease
Lead Sponsor:
Beijing Anzhen Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The CAD-MAP (Myocardial and Arterial Phenotype of Coronary Artery Disease) registry is initiated with the goal to describe the cardiac imaging map including epicardial coronary artery, coronary microc...
Detailed Description
Despite advances in medical therapy and the greater use of reperfusion therapy, morbidity and mortality following coronary artery disease (CAD) remains substantial, with increase in elder population a...
Eligibility Criteria
Inclusion
- 1\. Age ≥18 years old.
- 2\. Patients with suspected or confirmed coronary artery disease who are eligible to undergo coronary angiography and IVUS/OCT or functional examination.
- 3\. Written informed consent.
- 4\. Subject is willing to comply with all protocol-required follow-up evaluation.
Exclusion
- 1\. Malignant tumor, lymphoma, HIV-positive, or cirrhosis with life expectancy \<1 year.
- 2\. Pregnancy, lactation, or potentially fertile women.
- 3\. Patients who cannot complete this trial or comply with the protocol.
Key Trial Info
Start Date :
March 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06202300
Start Date
March 12 2023
End Date
June 30 2024
Last Update
January 11 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100029
2
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034